Jounce Therapeutics, Inc. is a clinical stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long‑lasting benefits to patients. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within tumors to prioritize targets, and then identifies related biomarkers designed to match the right therapy to the right patient. Jounce’s lead product candidate, JTX-2011, is a monoclonal antibody that binds to and activates ICOS and is currently in the Phase 2 portion of the Phase 1/2 ICONIC trial. For more information, please visit www.jouncetx.com.
To apply, please visit https://careers-jouncetx.icims.com/.
Jounce Therapeutics is seeking an experienced, energetic scientist to contribute to the development of novel therapeutics in the field of cancer immunotherapy. The successful candidate will be responsible for assisting multiple aspects of biomarker assay development, through the applications of classic and novel histologic techniques, coupled with image analysis so as to better understand the tumor micro-environment. As part of a multi-disciplinary team, s/he will be expected to proactively interact with project teams and external collaborators to provide insights and hands-on support to advance programs forward.
Jounce Therapeutics is an equal opportunity employer and does not discriminate in it’s employment decisions on the basis of race, color, national origin, age, physical or mental disability, marital status, religion, creed, sex, or political beliefs.
We offer a competitive salary and benefits package. All applicants should be legally entitled to work for any employer in the U.S.